Fresenius Medical Care AG & Co. FMS reported fourth-quarter 2025 adjusted earnings per share (EPS) of 83 cents, which surpassed the Zacks Consensus Estimate by 23.9%. The bottom line surged 59% year ...

After a five-month competitive prototype phase, PEO Enterprise’s Foreign Military Sales – Army Case Execution System (FMS-ACES) received authorization Sept. 20 to move into the execution phase of the ...

As of Tuesday, February 24, Fresenius Medical Care AG’s FMS share price has dipped by 6.71%, which has investors questioning if this is right time to buy.

On March 25, 2024, Program Executive Office Enterprise Information Systems’ (PEO EIS) Foreign Military Sales – Army Case Execution System (FMS-ACES) product office kicked off its competitive prototype ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. Featuring daily updates of ...

Fresenius Medical Care FMS recently unveiled its forward-looking “FME Reignite” strategy at the 2025 Capital Markets Day, aiming to achieve industry-leading profitability while optimizing capital ...

Discover what makes FMS Dental a trusted name in a rapidly growing healthcare market. From advanced technology and expert specialists to patient-centric care and global standards, explore why ...

Lockheed Martin will serve as the principal contractor for the potential $500 million foreign military sale of M142 High Mobility Artillery Rocket System and related equipment to Bahrain. The U.S.